Almoosa Health Company (4018.SR) — Cash flow
Operating, investing, and financing cash flow for Almoosa Health Company — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | 237↑150.5% | 94↓3.8% | 98↑92.4% | 51↓18.3% | 62 | |
| Depreciation & Amortization | 96↑15.5% | 83↑26.1% | 66↑13.4% | 58↑104.5% | 28 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -155↓439.6% | -29↑81.0% | -151↓3.9% | -145↓265.6% | 88 | |
| Accounts Receivable | -138↓226.7% | -42↑74.6% | -167↓129.0% | -73↓3433.3% | 2 | |
| Inventory | -10↓12.9% | -9↑5.2% | -9↓5592.7% | -0.16↑97.9% | -8 | |
| Accounts Payable | -17↓140.4% | 43↑1263.2% | 3↑106.3% | -50↓166.1% | 75 | |
| Other Working Capital | 10↑150.6% | -21↓193.1% | 22↑198.5% | -22↓224.6% | 18 | |
| Other Non-Cash Items | 3↓91.0% | 35↑29.8% | 27↑7.3% | 25↑29.9% | 19 | |
| Net Cash from Operating Activities | 181↓1.6% | 184↑358.4% | 40↑465.2% | -11↓105.5% | 198 | |
| Operating Cash Flow | 181↓1.6% | 184↑358.4% | 40↑465.2% | -11↓105.5% | 198 | |
| Investing Activities | ||||||
| Investment in Property, Plant & Equipment | -531↓101.5% | -264↑36.8% | -417↓34.6% | -310↑2.7% | -319 | |
| Capital Expenditure | -528↓105.2% | -257↑38.0% | -415↓35.2% | -307↑3.5% | -318 | |
| Acquisitions | 3↑94.8% | 1↓94.1% | 23↑83791.1% | 0.03↑48.6% | 0.02 | |
| Purchases of Investments | -190 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 101 | 0.00 | 0.00 | 0.00↓100.0% | 3 | |
| Other Investing Activities | 0.00 | 0.00↑100.0% | -60 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -617↓135.3% | -262↑42.3% | -454↓46.6% | -310↑1.7% | -315 | |
| Financing Activities | ||||||
| Net Debt Issuance | -610↓596.7% | 123↓70.8% | 421↑47.4% | 286↑91.8% | 149 | |
| Long-Term Net Debt Issuance | 0.00 | 0.00 | 0.00↓100.0% | 286↑91.8% | 149 | |
| Short-Term Net Debt Issuance | -610↓596.7% | 123↓70.8% | 421 | 0.00 | 0.00 | |
| Net Stock Issuance | 1,141 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 1,141 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 1,141 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -86↓516.7% | -14 | 0.00 | 0.00↑100.0% | -16 | |
| Common Dividends Paid | -86↓516.7% | -14 | 0.00 | 0.00↑100.0% | -16 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -9↓13.4% | -8↓29.1% | -6↑19.6% | -8↑0.0% | -8 | |
| Net Cash from Financing Activities | 436↑332.3% | 101↓75.7% | 415↑49.2% | 278↑121.2% | 126 | |
| Cash Reconciliation | ||||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Change in Cash | 0.07↓99.7% | 22 | 0.00 | 0.00 | 0.00 | |
| Cash at Beginning of Period | 38↑141.2% | 16↑3.9% | 15↓73.8% | 58 | 0.00 | |
| Cash at End of Period | 38↑0.2% | 38↑141.2% | 16↑3.9% | 15↓73.8% | 58 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -347↓371.6% | -74↑80.4% | -375↓17.9% | -318↓163.5% | -121 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.